New Product: Aerocrine&#x27;s Niox Mino

Food Insecurity and the Dangers of Infant Formula Dilution

The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.

January 30th 2023

FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years

FDA accepts NDA for berotralstat in HEA patients aged 2 to 11 years | Image credit: Contemporary Pediatrics

Demystifying Infant Formula

The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).

October 11th 2022

FDA starts review of nutrients in infant formula

FDA approves pediatric indication for Optison ultrasound enhancing agent

According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."

USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit

This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.

Related Content

Food Insecurity and the Dangers of Infant Formula Dilution

The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.

January 30th 2023

FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years

Demystifying Infant Formula

The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).

October 11th 2022

FDA starts review of nutrients in infant formula

FDA approves pediatric indication for Optison ultrasound enhancing agent

According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."